Trademark: 97043461
Status Date
Friday, February 23, 2024
Filing Date
Friday, September 24, 2021
Published for Opposition
Tuesday, July 12, 2022
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Feb 24, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 23, 2024
Sou Extension 3 Granted
Feb 23, 2024
Sou Extension 3 Filed
Feb 23, 2024
Sou Teas Extension Received
Aug 25, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 23, 2023
Sou Extension 2 Granted
Aug 23, 2023
Sou Extension 2 Filed
Aug 23, 2023
Sou Teas Extension Received
Mar 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 28, 2023
Sou Extension 1 Granted
Feb 28, 2023
Sou Extension 1 Filed
Feb 28, 2023
Sou Teas Extension Received
Sep 6, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 12, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 12, 2022
Published For Opposition
Jun 22, 2022
Notification Of Notice Of Publication E-Mailed
Jun 6, 2022
Approved For Pub - Principal Register
Jun 5, 2022
Assigned To Examiner
Nov 24, 2021
Teas Change Of Correspondence Received
Nov 24, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 24, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 26, 2021
New Application Office Supplied Data Entered
Sep 28, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24